|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RESEARCH PAPER
1 Center for Vascular Biology, Department of Cell Biology, and 2 Center for Biomedical Imaging Technology, University of Connecticut Health Center, Farmington, Connecticut 06030-3501, USA; 3 Genetics of Disease and Development Branch, National Institutes of Diabetes, Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland 20892, USA
Vascular stabilization, a process by which nascent vessels are invested with mural cells, is important in angiogenesis. Here we describe the molecular basis of vascular stabilization regulated by sphingosine 1-phosphate (S1P), a platelet-derived lipid mediator. S1P1 receptor-dependent cell-surface trafficking and activation of the cell-cell adhesion molecule N-cadherin is essential for interactions between endothelial and mural cells. Endothelial cell S1P1/Gi/Rac pathway induces microtubule polymerization, resulting in trafficking of N-cadherin to polarized plasma membrane domains. S1P treatment modulated the phosphorylation of N-cadherin as well as p120-catenin and induced the formation of cadherin/catenin/actin complexes containing novel regulatory and trafficking factors. The net result of endothelial cell S1P1 receptor activation is the proper trafficking and strengthening of N-cadherin-dependent cell-cell adhesion with mural cells. Perturbation of N-cadherin expression with small interfering RNA profoundly attenuated vascular stabilization in vitro and in vivo. S1P-induced trafficking and activation of N-cadherin provides a novel mechanism for the stabilization of nascent blood vessels by mural cells and may be exploited to control angiogenesis and vascular diseases.
[Keywords: sphingosine 1-phosphate; cadherin; angiogenesis; vascular stabilization; endothelial cells; pericytes]
Received June 2, 2004; revised version accepted August 11, 2004.
Article published online ahead of print. Article and publication date are at http://www.genesdev.org/cgi/doi/10.1101/gad.1227804.
4 Corresponding author.
E-MAIL hla{at}nso2.uchc.edu; FAX (860) 679-1201.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. J.B. Sabatini, M. Zhang, R. Silverman-Gavrila, M. P. Bendeck, and B. L. Langille Homotypic and Endothelial Cell Adhesions via N-Cadherin Determine Polarity and Regulate Migration of Vascular Smooth Muscle Cells Circ. Res., August 15, 2008; 103(4): 405 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dejana, F. Orsenigo, and M. G. Lampugnani The role of adherens junctions and VE-cadherin in the control of vascular permeability J. Cell Sci., July 1, 2008; 121(13): 2115 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kohno and Y. Igarashi Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P. Genes Cells, July 1, 2008; 13(7): 747 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Murakami, A. Elfenbein, and M. Simons Non-canonical fibroblast growth factor signalling in angiogenesis Cardiovasc Res, May 1, 2008; 78(2): 223 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Oyama, N. Sugimoto, X. Qi, N. Takuwa, K. Mizugishi, J. Koizumi, and Y. Takuwa The lysophospholipid mediator sphingosine-1-phosphate promotes angiogenesis in vivo in ischaemic hindlimbs of mice Cardiovasc Res, May 1, 2008; 78(2): 301 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Au, J. Tam, D. Fukumura, and R. K. Jain Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature Blood, May 1, 2008; 111(9): 4551 - 4558. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Wacker, S. K. Alford, E. A. Scott, M. Das Thakur, G. D. Longmore, and D. L. Elbert Endothelial Cell Migration on RGD-Peptide-Containing PEG Hydrogels in the Presence of Sphingosine 1-Phosphate Biophys. J., January 1, 2008; 94(1): 273 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ghosh, H. Wang, Y. Ai, E. Romeo, J. P. Luyendyk, J. M. Peters, N. Mackman, S. K. Dey, and T. Hla COX-2 suppresses tissue factor expression via endocannabinoid-directed PPAR{delta} activation J. Exp. Med., September 3, 2007; 204(9): 2053 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Keskitalo, T. Tammela, J. Lyytikka, T. Karpanen, M. Jeltsch, J. Markkanen, S. Yla-Herttuala, and K. Alitalo Enhanced Capillary Formation Stimulated by a Chimeric Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor-C Silk Domain Fusion Protein Circ. Res., May 25, 2007; 100(10): 1460 - 1467. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Oo, S. Thangada, M.-T. Wu, C. H. Liu, T. L. Macdonald, K. R. Lynch, C.-Y. Lin, and T. Hla Immunosuppressive and Anti-angiogenic Sphingosine 1-Phosphate Receptor-1 Agonists Induce Ubiquitinylation and Proteasomal Degradation of the Receptor J. Biol. Chem., March 23, 2007; 282(12): 9082 - 9089. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Hall Review of the Pericyte during Angiogenesis and its Role in Cancer and Diabetic Retinopathy Toxicol Pathol, October 1, 2006; 34(6): 763 - 775. [Full Text] [PDF] |
||||
![]() |
S. Liebner, U. Cavallaro, and E. Dejana The Multiple Languages of Endothelial Cell-to-Cell Communication Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1431 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. LaMontagne, A. Littlewood-Evans, C. Schnell, T. O'Reilly, L. Wyder, T. Sanchez, B. Probst, J. Butler, A. Wood, G. Liau, et al. Antagonism of Sphingosine-1-Phosphate Receptors by FTY720 Inhibits Angiogenesis and Tumor Vascularization Cancer Res., January 1, 2006; 66(1): 221 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. I. Singer, M. Tian, L. A. Wickham, J. Lin, S. S. Matheravidathu, M. J. Forrest, S. Mandala, and E. J. Quackenbush Sphingosine-1-Phosphate Agonists Increase Macrophage Homing, Lymphocyte Contacts, and Endothelial Junctional Complex Formation in Murine Lymph Nodes J. Immunol., December 1, 2005; 175(11): 7151 - 7161. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Armulik, A. Abramsson, and C. Betsholtz Endothelial/Pericyte Interactions Circ. Res., September 16, 2005; 97(6): 512 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lehti, E. Allen, H. Birkedal-Hansen, K. Holmbeck, Y. Miyake, T.-H. Chun, and S. J. Weiss An MT1-MMP-PDGF receptor-{beta} axis regulates mural cell investment of the microvasculature Genes & Dev., April 15, 2005; 19(8): 979 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Luo and G. L. Radice N-cadherin acts upstream of VE-cadherin in controlling vascular morphogenesis J. Cell Biol., April 11, 2005; 169(1): 29 - 34. [Abstract] [Full Text] [PDF] |
||||